Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Takeda and Biological E Limited a leading vaccines and pharmaceuticals company based in India announced today a strategic partnership to accelerate access to QDENGA multidose vials
Societal CDMO Inc a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development
Viatris Inc a global healthcare company and Idorsia Ltd today announced they have entered into agreements for a significant global research and development collaboration under which Viatris will receive exclusive global development
Amneal Pharmaceuticals Inc today announced that it has entered into an exclusive licensing agreement with Zambon Biotech SA part of the Zambon group for IPX in the European Union United Kingdom and Switzerland
Greenwich LifeSciences Inc a clinicalstage biopharmaceutical company focused on its Phase III clinical trial Flamingo which is evaluating GLSI an immunotherapy to prevent breast cancer recurrences today provided the following update on the
Amgen today announced the opening of its manufacturing site in Central Ohio the newest in its global operations network and the most advanced facility to date Our new facility known as Amgen Ohio was designed with the latest innovation
NGM Biopharmaceuticals Inc a biotechnology company focused on discovering and developing transformative therapeutics for patients today announced that it has entered into a definitive Agreement and Plan of Merger
Coeptis Therapeutics Holdings Inc a biopharmaceutical company developing innovative cell therapy platforms for cancer autoimmune and infectious diseases
TG Therapeutics Inc today announced that its exUS partner Neuraxpharm Group a leading European specialty pharmaceutical company focused on the treatment of central nervous system
BeiGene Ltd a global oncology company today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion recommending approval of tislelizumab as a treatment for
